Immunohistochemistry as Surrogate Marker for Molecular Typing of Special Types of Breast Carcinomas

Journal of Evidence Based Medicine and Healthcare

doi 10.18410/jebmh/2016/1063

Full Text

Abstract

Available in

Date

Authors

Publisher

Level Up Business Center

Related search

Molecular-Based Tumour Subtypes of Canine Mammary Carcinomas Assessed by Immunohistochemistry

BMC Veterinary Research
MedicineVeterinary
2010English

The Pathology of Familial Breast Cancer: Immunohistochemistry and Molecular Analysis

Breast Cancer Research
Cancer ResearchOncology
1999English

Identification of EZH2 as a Molecular Marker for a Precancerous State in Morphologically Normal Breast Tissues

Cancer Research
Cancer ResearchOncology
2006English

RAD51 as a Potential Surrogate Marker for DNA Repair Capacity in Solid Malignancies

International Journal of Cancer
Cancer ResearchOncology
2017English

Cytokeratin 14 as a Marker of Squamous Differentiation in Transitional Cell Carcinomas.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1997English

Serological Normalisation as a Surrogate Marker for Minimal Residual Disease Negativity in Multiple Myeloma

British Journal of Haematology
Hematology
2018English

Blood Samples Drawn for Culture as a Surrogate Marker for Case-Mix Adjustment of Hospital Antibiotic Use

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2007English

Impact of Polysomy 17 on HER-2/neu Immunohistochemistry in Breast Carcinomas Without HER-2/neu Gene Amplification

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2003English

Histomorphology and Immunohistochemical Surrogate Molecular Profile of Carcinoma Breast- A One-Year Study

Journal of Evidence Based Medicine and Healthcare
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy